Skip to main content
. 2016 Mar 23;11(3):e0151960. doi: 10.1371/journal.pone.0151960

Fig 3. Plasma MPO concentrations in PCOS and control subjects (A) and in control, PCOS non-IR and PCOS IR subjects (B).

Fig 3

*p<0.05 and **p<0.01 vs. Control; ap<0.05 between PCOS non-IR and PCOS IR subjects.